Navigation Links
Ninety Percent of Polled Pain Care Professionals Express Fear of Regulation
Date:9/7/2007

Delegates to PAINWeek 2007 Provide Sampling of Healthcare Professionals in

Context of Pain Management

LAS VEGAS, Sept. 7 /PRNewswire/ -- When asked to assess their level of fear of government regulation of their pain management practices, nearly half of 200 health care professionals surveyed during PAINWeek 2007 said the threat of regulation had "significant" or "high" impact on their practice. Approximately 90 percent reported at least "low" impact.

The survey results come amid growing controversy surrounding use of opioids - the strongest class of painkillers - and physicians' willingness to prescribe them.

In March, the state of Washington became the first state in the nation to adopt a suggested daily limit on opioid doses.

"What is at stake here is the well-being of tens of millions of Americans who suffer with pain," explained American Society of Pain Educators Executive Director B. Eliot Cole, MD, MPA. "Clearly, increased regulation would have a disastrous, chilling effect on care givers' ability to manage patients' bona fide, diagnosed pain."

Additionally, when asked about the importance of putting oversight of medical decisions in the hands of medical professionals as opposed to law enforcement regulators, 69 percent of those surveyed called that "most important" to their ability to manage their patients' pain.

According to 43 percent of PAINWeek delegates, lack of adequate pain management education during their professional training has a high-impact on their ability to provide appropriate pain management to their patients.

Nearly a dozen national medical associations and 700 delegates devoted to the practice of pain management are gathered at PAINWeek 2007, the first conference of its kind, in Las Vegas. The four-day conference provides a unique environment for the participating organizations to share their expertise with frontline healthcare practitioners.

Participating organ
'/>"/>

SOURCE PAINWeek 2007
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Vaccine Ninety Percent Effective Against Cervical Cancer
2. Pharmacia may take 51.5 percent Abbott stake
3. 45 Percent Of Errors In Cancer Diagnosis Harm The Patient
4. Zyflamend inhibits 78 percent of prostate cancer cells
5. Births Out Of Wedlock Increased To 42 Percent in 2004 in the UK
6. Community Dentists To Receive 10 Percent Salary Boost
7. NHS Forced to Borrow Money at Rates of 10 percent
8. Almost 30 Percent Dentists Refuse To Sign NHS Contracts
9. Polyunsaturated Fats And Vitamin E Cut MND Risk By 60 Percent
10. More Than 50 Percent Indians Aged Over 40 Have Diabetes, High Blood Pressure
11. Around 20 Percent Take-Out Foods Are Unhygienic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Adenna, Inc ., worldwide supplier of high-quality, ... the launch of Enov8 (pronounced “innovate”), one ... (PE) and approved by the U.S. FDA for patient ... The Enov8 glove might look like the PE gloves ... our proprietary formula and production technology brings to life ...
(Date:5/26/2015)... MN (PRWEB) May 26, 2015 Learning ... product line, Nutrition Education Cards . These cards ... Featuring engaging photography and simple, easy-to-read text, these new ... educators . They offer practical nutrition tips and suggestions ... Current titles available are: , + MyPlate: Eat for ...
(Date:5/26/2015)... Many sexy cocktail dresses inspired by ... collections recently. Now, TheCelebrityDresses.com is offering great discounts ... 70% off. The company aims to help ladies ... of dollars on valuable, trendy formal outfits. , ... fashion special occasion dresses. Their dresses are popular ...
(Date:5/26/2015)... U.S. Food and Drug Administration (FDA) ... are extensive and can be difficult to understand. ... device companies comply with FDA regulations, compiled a list ... FDA requirements. , 1. Start researching early. ... be a lengthy process depending on the classification of ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Carl W. ... Pinehurst Surgical Center in Pinehurst, N.C. have launched a ... surgery patients about chronic sinusitis and the benefits of ... can be used to determine if someone is a ... about symptoms and other factors that can contribute to ...
Breaking Medicine News(10 mins):Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2
... (AMS), which affects about half of those ascending to heights ... pulmonary or cerebral edema. ,The interest of the general ... past 25 years. This change is partly due to media ... In spite of these apparent changes, it is unknown whether ...
... deadly bird flu since it is still rampant in the region, ... ,"I think countries in this part of the world have ... it, the virus is still circulating," said Shigeru Omi, WHO's regional ... We remain concerned. We must avoid human transmission," he told reporters ...
... patients who have already gone blind in one eye ... and Therapeutics Bulletin (DTB). ,But that is ... (NICE), the body responsible for guiding the NHS on ... (Lucentis) and pegaptanib (Macugen) are licensed in the UK ...
... Biotechnology Co., Ltd. announced that a team led by ... completed a study to assess clinical efficacy, safety, ... for patients with peripheral vascular disease of the lower ... research and treatments for ataxia, cerebral palsy, spinal cord ...
... Those involved in biological weapons programs should be logically liable ... it seems to have happened in US and the Centers ... research laboratory at Texas A&M University to stop all work ... investigating reports of lab workers infected with the category B ...
... personnel involved in the Iraqi invasion of 2003 have ... published ahead of print in Occupational and Environmental Medicine. ... combat to pierce armoured vehicles, and spontaneously combusts on ... breathed in or eaten/drunk in contaminated food/water. ...
Cached Medicine News:Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Bird Flu in Asia Still High Risk Says WHO Official 2Health News:Draft National Policy on Sight-saving Drugs unacceptable 2Health News:Adult Stem Cells Show Promise for Peripheral Vascular Disease 2Health News:Bio-defense Lab Ordered Shut Down as Researchers Get Infected 2Health News:Bio-defense Lab Ordered Shut Down as Researchers Get Infected 3Health News:Bio-defense Lab Ordered Shut Down as Researchers Get Infected 4
(Date:5/26/2015)... 26, 2015 Cellular testing ... ,What,s the future of technologies for screening cells? ... 2015. Stay ahead there for data, benefiting your ... results, R&D, opportunities and revenue forecasts. ... you what,s possible for cell-based assays ...
(Date:5/26/2015)... LONDON , May 26, 2015 ... Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma ... dolutegravir 50mg, for Tentative Approval, to the Food and ... is the first ANDA for a generic version of ... Tivicay® (dolutegravir) for sale in the United ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 /PRNewswire/ ... and Flatiron Health today announced a ... cloud-based, electronic health record (EHR), data analytics and decision ... Together, the companies will build upon their existing respective ... radiation oncology and data analytics product suite. ...
Breaking Medicine Technology:Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 2Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 3Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 4
... – Intercell AG (VSE,“ICLL”) has been informed by ... results of a Phase I study involving,in total ... of different doses of the Staphylococcus aureus,vaccine. , ... conserved protein,antigen discovered by Intercell’s Antigen Identification,Program (AIP®) ...
... for New Combination, PARSIPPANY, N.J., May 21, ... amlodipine besylate with the angiotensin,receptor blocker olmesartan ... and diastolic blood pressure in,patients with hypertension, ... of Hypertension's Twenty-Second Annual Scientific,Meeting and Exposition ...
Cached Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3
... pedicle screw insertion assembly incorporates slotted ... construct locking. The PathFinder MIS System ... the pedicle screw insertion assembly incorporates ... insertion. The evolutionary Pathfinder MIS pedicle ...
Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide....
Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide....
... Impacted Instrument Set offers maximum distraction with ... offered by the Tangent Posterior Impacted Instrument ... ability to reproduce the technique. Set offers ... vertebral body distraction. A variety of sizes ...
Medicine Products: